For example, the use of the modified vaccinia ankara (MVA) virus expressing p53 is now used in combination with chemotherapy to treat ovarian cancer and with pembrolizumab to treat advanced breast/pancreatic/liver/head and neck cancer (Hardwick et al., 2018; Chung et al., 2019). The gene discussed is TP53; the disease is ovarian cancer.